Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Wegovys full approval for this indication is dependent on additional clinical trial data confirming its safety and efficacy
The SURMOUNT-4 study, a randomized clinical trial of continued maintenance of weight reduction in adults with obesity, treated participants with weekly doses of tirzepatide for 36 weeks
Clinicians should monitor patients for changes in substance use patterns after initiating GLP-1 therapy
P., Christensen, R
US$ 24.77
US$ 28.38
US$ 27.59
US$ 24.65
US$ 26.94
US$ 29.48
US$ 29.66
